대한당뇨병학회

[KDA] Diabetes and Metabolism Journal-November 2023 issue now open (Vol. 47, No. 6)

2023.12.19
관리자
조회 83

[KDA] Diabetes and Metabolism Journal-November 2023 issue now open (Vol. 47, No. 6)

http://e-dmj.org

Diabetes & Metabolism Journal

Indexed in SCIE, Medline

Table of Contents

Vol. 47 No. 6 (November 2023)

Lifestyle

Type 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and Therapies

J Mesinovic, JJ Fyfe, J Talevski, MJ Wheeler, GK Leung, ES George, MT Hunegnaw, C Glavas, P Jansons, RM Daly, D Scott

Diabetes Metab J. 2023 Nov;47(6):719-742.

Complications

Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy

HN Jang, TJ Oh

Diabetes Metab J. 2023 Nov;47(6):743-756.

Pathophysiology

Immune-Checkpoint Inhibitors-Induced Type 1 Diabetes Mellitus: From Its Molecular Mechanisms to Clinical Practice

YK Cho, CH Jung

Diabetes Metab J. 2023 Nov;47(6):757-766.

Ensuring Heathy Lives with the Korea Disease Control and Prevention Agency: Partnership with the Korean Diabetes Association

Y Jee

Diabetes Metab J. 2023 Nov;47(6):767-768.

Navigating the Future of Diabetes Treatment with New Drugs: Focusing on the Possibilities and Prospects of Enavogliflozin

SY Rhee

Diabetes Metab J. 2023 Nov;47(6):769-770.

Basic Research

Effects Of Exercise Training And Chlorogenic Acid Supplementation On Hepatic Lipid Metabolism In Prediabetes Mice

S Shirkhani, SM Marandi, MH Nasr-Esfahani, SK Kim

Diabetes Metab J. 2023 Nov;47(6):771-783.

Basic Research

Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition

HG Lee, IH Jung, BS Park, HR Yang, KK Kim, TH Tu, JY Yeh, S Lee, S Yang, BJ Lee, JG Kim, IS Nam-Goong

Diabetes Metab J. 2023 Nov;47(6):784-795.

Drug/Regimen

Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial

KA Han, YH Kim, DM Kim, BW Lee, S Chon, TS Sohn, IK Jeong, EG Hong, JW Son, JJ Nah, HR Song, SI Cho, SA Cho, KH Yoon

Diabetes Metab J. 2023 Nov;47(6):796-807.

Drug/Regimen

Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension

JS Moon, IR Park, HJ Kim, CH Chung, KC Won, KA Han, CY Park, JC Won, DJ Kim, GP Koh, ES Kim, JM Yu, EG Hong, CB Lee, KH Yoon

Diabetes Metab J. 2023 Nov;47(6):808-817.

Drug/Regimen

The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study

JS Moon, IR Park, SS Kim, HS Kim, NH Kim, SG Kim, SH Ko, JH Lee, I Lee, BK Lee, KC Won

Diabetes Metab J. 2023 Nov;47(6):818-825.

Technology/Device

Clinical and Lifestyle Determinants of Continuous Glucose Monitoring Metrics in Insulin-Treated Patients with Type 2 Diabetes Mellitus

DY Lee, N Kim, I Jung, SY Park, JH Yu, JA Seo, J Kim, KJ Kim, NH Kim, HJ Yoo, SG Kim, KM Choi, SH Baik, SM Park, NH Kim

Diabetes Metab J. 2023 Nov;47(6):826-836.

Cardiovascular Risk/Epidemiology

Comparison of on-Statin Lipid and Lipoprotein Levels for the Prediction of First Cardiovascular Event in Type 2 Diabetes Mellitus

JY Kim, J Choi, SG Kim, NH Kim

Diabetes Metab J. 2023 Nov;47(6):837-845.

Metabolic Risk/Epidemiology

Differential Impact of Obesity on the Risk of Diabetes Development in Two Age Groups: Analysis from the National Health Screening Program

TK Yoo, KD Han, YH Kim, GE Nam, SH Park, EJ Rhee, WY Lee

Diabetes Metab J. 2023 Nov;47(6):846-858.

Metabolic Risk/Epidemiology

Prediabetes Progression and Regression on Objectively- Measured Physical Function: A Prospective Cohort Study

S Qiu, Y Zhu, B Xie, W Chen, D Wang, X Cai, Z Sun, T Wu

Diabetes Metab J. 2023 Nov;47(6):859-868.

Complications

The Risk of Shoulder Adhesive Capsulitis in Individuals with Prediabetes and Type 2 Diabetes Mellitus: A Longitudinal Nationwide Population-Based Study

JH Kim, BS Kim, Kd Han, HS Kwon

Diabetes Metab J. 2023 Nov;47(6):869-878.

Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)

DY Lee

Diabetes Metab J. 2023 Nov;47(6):879-881.

Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)

NN Scherbak, R Kruse, T Nyström, J Jendle

Diabetes Metab J. 2023 Nov;47(6):882-883.

Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr
Copyright © The Korean Diabetes Association.

DMJ 뉴스레터

이메일 무단 수집 거부